Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective–prospective cohort multicentre study

被引：0
|
作者：
Alvydas Cesas
Vincas Urbonas
Skaiste Tulyte
Rasa Janciauskiene
Sigita Liutkauskiene
Ingrida Grabauskyte
Ignas Gaidamavicius
机构：
[1] Klaipeda University Hospital,Clinic of Internal Diseases, Family Medicine and Oncology, Faculty of Medicine, Institute of Clinical Medicine
[2] National Cancer Institute,Clinic of Oncology and Hematology, Institute of Oncology
[3] Vilnius University,Hospital of Oncology
[4] Lithuanian University of Health Sciences Hospital of Lithuania,Department of Physics, Mathematics and Biophysics
[5] Kaunas Clinics Hospital,undefined
[6] Affiliate Hospital of Lithuanian University of Health Sciences,undefined
[7] Lithuanian University of Health Sciences,undefined
[8] UAB “Guruma”,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
mRCC; VEGF; PFS; PFS2; Treatment sequence; Real-world data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6979 / 6988
页数：9
相关论文
共 50 条
  • [1] Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective-prospective cohort multicentre study
    Cesas, Alvydas
    Urbonas, Vincas
    Tulyte, Skaiste
    Janciauskiene, Rasa
    Liutkauskiene, Sigita
    Grabauskyte, Ingrida
    Gaidamavicius, Ignas
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 6979 - 6988
  • [2] Treatment Patterns: Targeted Therapies Indicated for First-Line Management of Metastatic Renal Cell Carcinoma in a Real-World Setting
    Hess, Gregory
    Borker, Rohit
    Fonseca, Eileen
    [J]. CLINICAL GENITOURINARY CANCER, 2013, 11 (02) : 161 - 167
  • [3] Treatment patterns: Targeted therapies indicated for first-line management of metastatic renal cell carcinoma in a real-world setting.
    Hess, Gregory P.
    Borker, Rohit
    Fonseca, Eileen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [4] Management of metastatic renal cell carcinoma following prior vascular endothelial growth factor-targeted therapy: A real-world retrospective study from Taiwan
    Chung, Hsiao-Jen
    Chang, Yen-Hwa
    Huang, Yi-Hsiu
    Lin, Tzu-Ping
    Wei, Tzu-Chun
    Lin, Fang-Ju
    Huang, Huai-Hsuan
    Wang, Hui-Chuan
    [J]. JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (04) : 438 - 442
  • [5] Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib
    Kim, Myung Soo
    Chung, Ho Seok
    Hwang, Eu Chang
    Jung, Seung Il
    Kwon, Dong Deuk
    Hwang, Jun Eul
    Bae, Woo Kyun
    Park, Jae Young
    Jeong, Chang Wook
    Kwak, Cheol
    Song, Cheryn
    Seo, Seong Il
    Byun, Seok-Soo
    Hong, Sung-Hoo
    Chung, Jinsoo
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (51)
  • [6] SUNITINIB TREATMENT MODIFICATION IN FIRST-LINE METASTATIC RENAL CELL CARCINOMA: ANALYSIS OF A REAL-WORLD SWEDISH COHORT
    Jakobsson, M.
    Nilsson, F.
    Strambi, A.
    Arpegard, J.
    Dalen, J.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S22 - S22
  • [7] First-line vascular endothelial growth factor targeted therapy in renal cell carcinoma: priming the tumor microenvironment for immunotherapy
    Tannir, Nizar
    Hammers, Hans
    Amin, Asim
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 825 - 831
  • [8] CASSIOPE: A prospective noninterventional study of cabozantinib treatment following prior vascular endothelial growth factor (VEGF) -targeted therapy in patients with advanced renal cell carcinoma (aRCC).
    Staehler, Michael D.
    Bigot, Pierre
    Barthelemy, Philippe
    Hamberg, Paul
    Suarez, Cristina
    Eymard, Jean-Christophe
    Gajate, Pablo
    Perrot, Valerie
    Qvick, Bryan
    Dutailly, Pascale
    Procopio, Giuseppe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma
    Chakiryan, Nicholas H.
    Jiang, Da David
    Gillis, Kyle A.
    Green, Elizabeth
    Hajiran, Ali
    Hugar, Lee
    Zemp, Logan
    Zhang, Jingsong
    Jain, Rohit K.
    Chahoud, Jad
    Spiess, Philippe E.
    Sexton, Wade
    Gilbert, Scott M.
    Manley, Brandon J.
    [J]. JAMA NETWORK OPEN, 2021, 4 (05) : E2111329
  • [10] Real-world efficacy of sequential nivolumab for metastatic renal cancer after first-line molecular targeting therapy
    Obinata, Daisuke
    Funakoshi, Daigo
    Sakurai, Fuminori
    Yoshizawa, Tsuyoshi
    Mochida, Junichi
    Yamaguchi, Kenya
    Takahashi, Satoru
    [J]. MEDICINE, 2022, 101 (32) : E29510
12345